CLINE CHRISTOPHER R. (CHIEF FINANCIAL OFFICER) sold 0.5% of their position (642.00 shares) of TRAVERE THERAPEUTICS, INC. on the open market
Open‑market sale worth $42.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/3/2026ACC: 0001943192-26-000005
Officer· CHIEF FINANCIAL OFFICER
Since Feb 2026
-642.00
Net shares
Net seller
$42.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
642.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−642.00
Price / share
$66.37
Trade value
$42.61K
% of position
0.5%
9/2/2026
118.66K→118.02K
Total
Net shares
−642.00
Net value
-$42.61K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/2/2026 | S · Sale | −642.00 | $66.37 | $42.61K | 0.5% | 118.66K | 118.02K |
| Total | −642.00 | -$42.61K | ||||||
Derivative Transactions0
No derivative transactions reported